These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 16847887

  • 1. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
    Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Chansky K, Kelly K, Adjei AA, Jett JR.
    Cancer; 2006 Aug 15; 107(4):781-92. PubMed ID: 16847887
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R.
    Cancer; 2001 Oct 01; 92(7):1896-904. PubMed ID: 11745263
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P, Li J, Ge LP, Dai CH, Li XQ.
    Respirology; 2010 Apr 01; 15(3):501-9. PubMed ID: 20210890
    [Abstract] [Full Text] [Related]

  • 7. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
    Maione P, Rossi A, Di Maio M, Gridelli C.
    Lung Cancer; 2009 Oct 01; 66(1):8-14. PubMed ID: 19328587
    [Abstract] [Full Text] [Related]

  • 8. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.
    Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK.
    Cancer; 2006 Jun 01; 106(11):2428-36. PubMed ID: 16634096
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
    Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K.
    Clin Cancer Res; 1997 Jan 01; 3(1):47-50. PubMed ID: 9815536
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors in stage III non-small-cell lung cancer.
    Ademuyiwa FO, Johnson CS, White AS, Breen TE, Harvey J, Neubauer M, Hanna NH.
    Clin Lung Cancer; 2007 Sep 01; 8(8):478-82. PubMed ID: 17922971
    [Abstract] [Full Text] [Related]

  • 11. Mental state as a possible independent prognostic variable for survival in patients with advanced lung carcinoma.
    Nakahara Y, Mochizuki Y, Miyamoto Y, Tanaka A, Kawamura T, Sasaki S, Nakahara Y, Katsura Y.
    Cancer; 2002 Jun 01; 94(11):3006-15. PubMed ID: 12115391
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.
    Dtsch Med Wochenschr; 2006 Nov 24; 131(47):2643-8. PubMed ID: 17109272
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.
    Jatoi A, Hillman S, Stella P, Green E, Adjei A, Nair S, Perez E, Amin B, Schild SE, Castillo R, Jett JR, North Central Cancer Treatment Group.
    J Clin Oncol; 2005 Dec 20; 23(36):9113-9. PubMed ID: 16361618
    [Abstract] [Full Text] [Related]

  • 17. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
    Zell JA, Ou SH, Ziogas A, Anton-Culver H.
    Cancer; 2008 Jan 01; 112(1):136-43. PubMed ID: 17960795
    [Abstract] [Full Text] [Related]

  • 18. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O, Ishii G, Kubota K, Murata Y, Naito Y, Mizuno T, Aokage K, Saijo N, Nishiwaki Y, Gemma A, Kudoh S, Ochiai A.
    Cancer; 2008 Sep 15; 113(6):1387-95. PubMed ID: 18671239
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR, SWOG S9712.
    J Clin Oncol; 2006 Nov 20; 24(33):5242-6. PubMed ID: 17114656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.